Bridging paradigms and shaping the future of resectable gastric cancer: a narrative review of the post-MATTERHORN era.

Gastroenterol Rep (Oxf) · 2026 · PMC12970996 · PMID 41809424

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In TOPGEAR, patients with GEJ adenocarcinoma showed a trend toward improved OS with CRT (HR 0.78; 95% CI 0.55–1.12) [ 21 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.